Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred Saad

Showing results (561-570 of 993) with videos related to

Pageof 100
Sort By:
European Urology|December 17, 2021
Deep Prostate-specific Antigen Response following Addition of Apalutamide to Ongoing Androgen Deprivation Therapy and Long-term Clinical Benefit in SPARTANFred Saad, Eric J Small, Felix Y Feng, et al.
Clinical Genitourinary Cancer|February 1, 2020
Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival OutcomesFrancesco A Mistretta, Sarah-Jeanne Cyr, Stefano Luzzago, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2017
Cabazitaxel Versus Docetaxel As First-Line Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial-FIRSTANAStéphane Oudard, Karim Fizazi, Lisa Sengeløv, et al.
World Journal of Urology|August 26, 2021
The impact of race/ethnicity on upstaging and/or upgrading rates among intermediate risk prostate cancer patients treated with radical prostatectomyLuigi Nocera, Mike Wenzel, Claudia Collà Ruvolo, et al.
Npj Imaging|July 3, 2025
Artificial intelligence unravels interpretable malignancy grades of prostate cancer on histology imagesOkyaz Eminaga, Fred Saad, Zhe Tian, et al.
Frontiers in Oncology|September 5, 2022
The effect of race/ethnicity on cancer-specific mortality after salvage radical prostatectomyMike Wenzel, Christoph Würnschimmel, Luigi Nocera, et al.
The Lancet. Oncology|September 5, 2022
Patient-reported outcomes with olaparib plus abiraterone versus placebo plus abiraterone for metastatic castration-resistant prostate cancer: a randomised, double-blind, phase 2 trialFred Saad, Antoine Thiery-Vuillemin, Pawel Wiechno, et al.
Critical Reviews in Oncology/Hematology|November 25, 2021
Immuno-oncology therapy in metastatic bladder cancer: A systematic review and network meta-analysisFrancesco Chierigo, Mike Wenzel, Christoph Würnschimmel, et al.
Urologia Internationalis|March 12, 2021
Higher Cancer Mortality in Rural Upper Urinary Tract Urothelial Carcinoma PatientsClaudia Collà Ruvolo, Lara F Stolzenbach, Luigi Nocera, et al.
World Journal of Urology|October 21, 2017
Does surgical delay for radical prostatectomy affect biochemical recurrence? A retrospective analysis from a Canadian cohortMarc Zanaty, Mansour Alnazari, Khaled Ajib, et al.
Pageof 100

Showing results (561-570 of 993) with videos related to

Sort By:
Pageof 100
European Urology|December 17, 2021
Deep Prostate-specific Antigen Response following Addition of Apalutamide to Ongoing Androgen Deprivation Therapy and Long-term Clinical Benefit in SPARTANFred Saad, Eric J Small, Felix Y Feng, et al.
Clinical Genitourinary Cancer|February 1, 2020
Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival OutcomesFrancesco A Mistretta, Sarah-Jeanne Cyr, Stefano Luzzago, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2017
Cabazitaxel Versus Docetaxel As First-Line Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial-FIRSTANAStéphane Oudard, Karim Fizazi, Lisa Sengeløv, et al.
World Journal of Urology|August 26, 2021
The impact of race/ethnicity on upstaging and/or upgrading rates among intermediate risk prostate cancer patients treated with radical prostatectomyLuigi Nocera, Mike Wenzel, Claudia Collà Ruvolo, et al.
Npj Imaging|July 3, 2025
Artificial intelligence unravels interpretable malignancy grades of prostate cancer on histology imagesOkyaz Eminaga, Fred Saad, Zhe Tian, et al.
Frontiers in Oncology|September 5, 2022
The effect of race/ethnicity on cancer-specific mortality after salvage radical prostatectomyMike Wenzel, Christoph Würnschimmel, Luigi Nocera, et al.
The Lancet. Oncology|September 5, 2022
Patient-reported outcomes with olaparib plus abiraterone versus placebo plus abiraterone for metastatic castration-resistant prostate cancer: a randomised, double-blind, phase 2 trialFred Saad, Antoine Thiery-Vuillemin, Pawel Wiechno, et al.
Critical Reviews in Oncology/Hematology|November 25, 2021
Immuno-oncology therapy in metastatic bladder cancer: A systematic review and network meta-analysisFrancesco Chierigo, Mike Wenzel, Christoph Würnschimmel, et al.
Urologia Internationalis|March 12, 2021
Higher Cancer Mortality in Rural Upper Urinary Tract Urothelial Carcinoma PatientsClaudia Collà Ruvolo, Lara F Stolzenbach, Luigi Nocera, et al.
World Journal of Urology|October 21, 2017
Does surgical delay for radical prostatectomy affect biochemical recurrence? A retrospective analysis from a Canadian cohortMarc Zanaty, Mansour Alnazari, Khaled Ajib, et al.
Pageof 100